Pneumo Update Europe 2023

The 10-th Pneumo Update Europe is taking place on June 23 and 24, 2023 in the intriguing and beautiful Amsterdam, Netherlands – an annual meeting, especially interesting for young pulmologists, which should not be missed! For further information regarding the expert faculty and cutting-edge program please visit www.pneumo-update-europe.eu. Seize the opportunity and get back to us as soon as possible! All the active members of the Macedonian Respiratory Society can benefit from a discounted price for the registration fee of 250 € on-site or 150 € livestream .

11th Edition of the International Workshop on Lung Health

During the 3 Workshop days all the major and outbreaking topics of Respiratory Medicine: from Asthma and COPD to Respiratory Infections, will be addressed, reaching also the Interstitial and Rare Diseases, focusing on the most recent updates and perspectives, in terms of clinical advances and research outcomes.

3rd European Bronchiectasis workshop

The“3rd European Bronchiectasis workshop” (EBROW) shall take place in Milan, Italy from February 23rd to 25th , 2023. The main focus is on the latest outcomes related to the diagnosis and management of Bronchiectasis and its comorbidities.

PneumoUpdate 2022

The 9th Pneumo Update Europe is taking place on 10 – 11 June 2022 in beautiful Vienna – a yearly meeting that shouldn’t be missed! or further information regarding the expert faculty and cutting-edge program visit us at www.pneumo-update-europe.eu. Seize the opportunity, seats are limited (as we will be creating a safe event for all) and get back to us as soon as possible! All the active members of the Macedonian Respiratory Society can benefit from a discounted price for the registration fee of 300 € on-site or 150 € livestream .

ERS EBUS- part 1

Registrations are open for the upcoming EBUS Part 1 course. These courses will take place in Heidelberg and Amsterdam. They are part of the European Respiratory Society Certified Training Programme on Endobronchial Ultrasound (EBUS). The aim of this programme is to train qualified doctors to be able to independently and competently perform EBUS. For further information, visit: 👇https://www.ersnet.org/education-and-professional-development/ers-certified-training-programmes/endobronchial-ultrasound-ebus-certified-training-programme/.

EAACI Congress 2022

Registration is open for the largest conrgess in allergy , asthma and clinical immunology in Europe . The European Academy’s annual meeting will take place as a hybrid event at the O₂ universum venue in Prague, Czech Republic, and online on 1-3 July. Members of national allergy societies with dual agreements in place with EAACI can benefit from reduced registrations rates. More information on EAACI.org and the Macedonian respiratory Society, makrespir@gmail.com

ERS Annual Congress 2019, Sept 28 - Oct 02, 2019, Madrid,Spain

Welcoming over 20,000 delegates every year, the annual ERS Congress is a showcase of excellence across the entire field of respiratory medicine. ERS is pleased to announce that the ERS International Congress 2019 will be hosted in Madrid, Spain on 28 September to 2 October 2019 at IFEMA.

EAACI Congress 2019, June 1-5, 2019, Lisbon, Portugal

Organised by the European Academy of Allergy and Clinical Immunology (EAACI), Europe’s largest medical association in its field, the EAACI Congress 2019 on 1-5 June 2019 in Lisbon, Portugal, offers a unique opportunity to learn about the latest discoveries. The congress activities will be developed around the theme “Mapping the new world of allergy: towards precision medicine in allergy and asthma”. Health care professionals, key scientists and opinion leaders from all around the world will map the following topics: allergen structure, aerobiology, disease endotypes, biological treatments, immunotherapy and new developments in genomics, proteomics and metabolomics. Joining this meeting, you will be offered an excellent platform for knowledge exchange, learning and networking. Please clic on the title to discover the EAACI Congress 2019 scientific programme and register!.

Pneumo Update 2019

This year the fifth "Pneumo Update Europe" shall take place on June 14 and 15, 2019, in Prague, Czech Republic. The program encompasses carefully selected , contemporary subjects from the respiratory pathology. For the first time this year, the lectures shall be available free on-line, on demand , for the delegates of the meeting.

WORLD VILLAGE 2018, ERS Congress 2018, Paris, France

The Macedonian Respiratory Society took active part and was presented at the manifestation "World Village", at the Annual Congress of ERS, from September 15-19, Paris, France ( more information in news)

Pneumo Update Europe 2018- Budapest, 15-16 June 2018

Once more, this year, the Macedoinan Respiratory Society continues the collaboration with the elite meeting of experts in pulmology, Pneumo Update 2018. On June 15 and 16, 2018 in the Castle Garden Bazaar in Budapest, Hung aria, the participants shall benefit the possibility to hear about the actual accomplishments in the field of respiratory medicine, sublimated by the top professionals from Europe

Open letter concerning the initiative for liberalization of the smoking ban in Macedonia

In News: For the past several months we have been witnesses of debates in the public, the media, and on social networks with numerous positive and negative comments concerning the proposals for liberalization of the law for regulation of smoking in Macedonia. The Macedonian Respiratory Society is presenting its position concerning the proposed initiatives for liberalization of the smoking law in Macedonia.The initiative is supported by the Society of Pulmonologists of Republic of Macedonia

4th Pneumo Update Europe 2017 , 9 – 10 June 2017 in Vienna

On 9 – 10 June 2017 in Vienna, Austria the 4th Pneumo Update Europe 2017 shall take place. This esteemed gathering of experts in the field of pulmology, which, in a two day's, rich scientific program gives a sublimation of the latest accomplishments in the respiratory medicine, has become a traditional assembly of profesionals from the respiratory field

EU Grant Funding Announcement

Global Bridges and Pfizer Independent Grants for Learning and Change are pleased to announce $2 million in grant funding for 11 new projects focused on treating tobacco dependence in the World Health Organization (WHO) European Region. More information in News!

4 th International Workdhop on Lung Healh

Asthma and COPD - New paradigms in preventing exacerbations of respiratory diseases, Budapest, January 19-21, 2017

Pneumo Update Europe 2016

On June 24-25, 2016 the third Pneumo Update Europe shall take place in Prague, Czech Republic. Once again we are granted the opportunity to follow the rich two-day scientific program which sublimates the recent advances of the respiratory medicine

Interventional pulmology making its place through at the Pulmology and Allergy Clinic- endobronchial electrocautery

The team from the Department for ivasive diagnostics at the Pulmology and Allergy Clinic ( Dr Rexhepi, Dr Todevski, Dr Zdraveska, Prof Stefanovski), with assistance of the mobile team from he Clinic of anesthesiology, succesfuly extracted an endobronchial tumour with electrocauтery

Bronchiectasis guidelines 2015

On May 1, 2015 , the new bronchiectasis guidelines were published in the ERJ. The goals of treament focus on mobilisation of phlegm, suppression of bacterial colonization, reduction of airway imflammation and improvement of QoL

Evaluating he problem of COPD exacerbations

The ACCP issued the new guidelines for COPD egacerbations

Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controler treatment: a US administrative claims database study

This study compared the real–world effectiveness of approved budesonide/formoterol combination (BFC) and fluticasone/salmeterol combination (FSC) treatments among matched cohorts of chronic obstructive pulmonary disease (COPD) patients in a large US managed care setting. This study demonstrated no difference in COPD–related exacerbations or pneumonia events between BFC and FSC treatment groups for patients new to ICS/LABA treatment in a real–world setting.